Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT01397994
Eligibility Criteria:
Inclusion Criteria:
1. Patients of chronic stable angina with abnormal Exercise Myocardial Perfusion Spect Scan with reversible and partially reversible ischemic changes.
2. Male and female
3. Age 25 to 65 years
4. Patient must understand and be willing, able and likely to comply with all study procedures and restrictions and comprehends the diary cards.
5. Patient must be able to give voluntary written informed consent.
Exclusion Criteria:
1. Hypertension of \> 170/100 mm of Hg
2. Valvular heart disease and cardiomyopathy
3. Myocardial infarction in \< 6 months
4. Unstable angina
5. Congestive cardiac failure
6. Severe anemia (Hb 7G/dl)
7. Cardiac arrhythmias or II or III degree AV block
8. Significant liver or renal dysfunction
9. IDDM (Type-1 diabetes mellitus)
10. Systolic blood pressure \< 100 mm Hg
11. Pregnant and nursing women
12. Known hypersensitivity to nicorandil
13. On calcium channel blockers
14. Patients not eligible for Tc 99m SPECT
15. Patients in whom beta blockers are contraindicated
16. Geographical inaccessibility for treatment or follow-up evaluations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
65 Years
Study:
NCT01397994
Study Brief:
Protocol Section:
NCT01397994